UVA researchers take on antibiotic resistance crisis with $1.2 million grant

University of Virginia researchers are working to outrace two dangerous germs known for quickly developing resistance to new antibiotics – and the scientists’ efforts could help us better combat antibiotic resistance more broadly.

AD/PD 2024: Vaxxinity reveals Phase I success with Parkinson’s vaccine – Pharmaceutical Technology

Share this article Parkinson’s disease is caused by a loss of nerve cells in part of the brain. Credit: Ocskay Mark via Shutterstock. US-based biotech

March 8, 2024

HIF-2α inhibitor belzutifan significantly reduces progression of clear cell renal cell carcinoma

Belzutifan significantly reduced the risk of progression of clear cell renal cell carcinoma (ccRCC), the most common type of kidney cancer, in patients previously treated

October 24, 2023

PsychedeliCare Launches First European Citizens’ Initiative Demanding Political Action on Psychedelic-Assisted Therapies – Psychedelic Alpha

But the establishment of an expert consensus of standards in psychedelic care would “add legitimacy to the practice”. “Standardisation—of things like training protocols, patient safety,

January 14, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.